Joint profiling of immune-endothelial cells in sepsis: promise, pitfalls, and the path forward
Open Access
- 5 August 2026
- journal article
- Published by Elsevier in EBioMedicine
- Vol. 131
Abstract
No abstract availableFunding Information
- National Institute of General Medical Sciences (R21GM150093)
- National Institute of General Medical Sciences (R33GM151703)
- National Institute of General Medical Sciences (R35GM155165)
This publication has 10 references indexed in Scilit:
- Integrated immune and endothelial profiling predicts 90-day mortality in postoperative sepsis and septic shockEBioMedicine, 2026
- Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDSCritical Care, 2025
- Sepsis and Septic ShockNew England Journal of Medicine, 2024
- Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicineThe Lancet Respiratory Medicine, 2023
- Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsisNature Immunology, 2023
- Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective observational studyCritical Care, 2022
- Endothelial Responses in SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2020
- An immune-cell signature of bacterial sepsisNature Medicine, 2020
- Human Organ-Specific Endothelial Cell HeterogeneityiScience, 2018
- Characterization of Circulating Endothelial Cells in Acute Myocardial InfarctionScience Translational Medicine, 2012